The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...

The Cancer Vaccines Market is witnessing significant expansion, driven by rising cancer prevalence and advancements in ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for ...

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...

I think [this technology] will be among the most important things.' Similar experimental mRNA cancer vaccines have been in development since the technology was advanced during the Covid pandemic.

The latest guidance reduction was the second time in the last six months that the firm has revised its forecast in a negative ...

(MENAFN) Russia’s Gamaleya Research Institute, known for developing the Sputnik V COVID-19 vaccine, is close to gaining regulatory approval for a personalized mRNA cancer vaccine. According to ...

design a vaccine for every individual person to vaccinate them against that cancer and you can make that mRNA vaccine ...

The president announced a major AI investment project, which Oracle Chairman Larry Ellison said could be used to cure cancer.